NO301520B1 - Fremgangsmåte for fremstilling av et system for regulert frigjöring av aktive stoffer - Google Patents
Fremgangsmåte for fremstilling av et system for regulert frigjöring av aktive stoffer Download PDFInfo
- Publication number
- NO301520B1 NO301520B1 NO900428A NO900428A NO301520B1 NO 301520 B1 NO301520 B1 NO 301520B1 NO 900428 A NO900428 A NO 900428A NO 900428 A NO900428 A NO 900428A NO 301520 B1 NO301520 B1 NO 301520B1
- Authority
- NO
- Norway
- Prior art keywords
- release
- active
- active agent
- pharmaceutical
- excipient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- External Artificial Organs (AREA)
- Filling Or Discharging Of Gas Storage Vessels (AREA)
- Operation Control Of Excavators (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DD89325354A DD295760A5 (de) | 1989-01-31 | 1989-01-31 | Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung |
| DE19893932987 DE3932987A1 (de) | 1989-10-03 | 1989-10-03 | System fuer die kontrollierte freisetzung von wirkstoffen und verfahren zu seiner herstellung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO900428D0 NO900428D0 (no) | 1990-01-30 |
| NO900428L NO900428L (no) | 1990-08-01 |
| NO301520B1 true NO301520B1 (no) | 1997-11-10 |
Family
ID=25748261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO900428A NO301520B1 (no) | 1989-01-31 | 1990-01-30 | Fremgangsmåte for fremstilling av et system for regulert frigjöring av aktive stoffer |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0381181B1 (de) |
| JP (1) | JP2885858B2 (de) |
| AT (1) | ATE126052T1 (de) |
| AU (1) | AU641136B2 (de) |
| CA (1) | CA2009045A1 (de) |
| DE (1) | DE69021405T2 (de) |
| DK (1) | DK0381181T3 (de) |
| ES (1) | ES2078251T3 (de) |
| FI (1) | FI900470A7 (de) |
| GR (1) | GR3017861T3 (de) |
| HU (1) | HU205851B (de) |
| IE (1) | IE69174B1 (de) |
| NO (1) | NO301520B1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ238867A (en) * | 1990-07-12 | 1993-08-26 | Alza Corp | Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device |
| US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
| US6156343A (en) * | 1994-12-27 | 2000-12-05 | Akzo Nobel N.V. | Controlled release preparation |
| US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
| US6074669A (en) * | 1997-01-20 | 2000-06-13 | Ranbaxy Laboratories Limited | Controlled drug delivery system for diltiazem |
| JP4848101B2 (ja) * | 2001-08-17 | 2011-12-28 | 株式会社フジモト・コーポレーション | 徐放性マイクロペレット |
| EP1482914B1 (de) * | 2002-03-11 | 2015-04-22 | Novartis AG | Implantierbare arzneimittelabgabevorrichtung fürs auge |
| US8084058B2 (en) | 2002-09-20 | 2011-12-27 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US7959946B2 (en) | 2002-09-20 | 2011-06-14 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US9060941B2 (en) | 2002-09-20 | 2015-06-23 | Actavis, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
| US7785627B2 (en) | 2002-09-20 | 2010-08-31 | Watson Pharmaceuticals, Inc. | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| GB2150434B (en) * | 1983-12-01 | 1987-11-04 | Alza Corp | Constant rate release systems |
| US4753802A (en) * | 1986-03-19 | 1988-06-28 | Alza Corporation | Verapamil dosage form |
| ES2022454B3 (es) * | 1986-06-17 | 1991-12-01 | Recordati Ind Chimica E Farm S P A | Sistema terapeutico para la liberacion controlada de drogas. |
| US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
-
1990
- 1990-01-30 JP JP2021910A patent/JP2885858B2/ja not_active Expired - Lifetime
- 1990-01-30 HU HU90591A patent/HU205851B/hu not_active IP Right Cessation
- 1990-01-30 NO NO900428A patent/NO301520B1/no unknown
- 1990-01-30 FI FI900470A patent/FI900470A7/fi not_active IP Right Cessation
- 1990-01-30 IE IE33690A patent/IE69174B1/en not_active IP Right Cessation
- 1990-01-31 AU AU48988/90A patent/AU641136B2/en not_active Ceased
- 1990-01-31 DE DE69021405T patent/DE69021405T2/de not_active Expired - Fee Related
- 1990-01-31 CA CA002009045A patent/CA2009045A1/en not_active Abandoned
- 1990-01-31 EP EP90101888A patent/EP0381181B1/de not_active Expired - Lifetime
- 1990-01-31 AT AT90101888T patent/ATE126052T1/de not_active IP Right Cessation
- 1990-01-31 ES ES90101888T patent/ES2078251T3/es not_active Expired - Lifetime
- 1990-01-31 DK DK90101888.7T patent/DK0381181T3/da active
-
1995
- 1995-10-25 GR GR950402965T patent/GR3017861T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0381181A2 (de) | 1990-08-08 |
| FI900470A7 (fi) | 1990-08-01 |
| DK0381181T3 (da) | 1995-10-30 |
| NO900428L (no) | 1990-08-01 |
| HU900591D0 (en) | 1990-04-28 |
| IE900336L (en) | 1990-07-31 |
| GR3017861T3 (en) | 1996-01-31 |
| IE69174B1 (en) | 1996-08-07 |
| AU4898890A (en) | 1990-08-09 |
| ES2078251T3 (es) | 1995-12-16 |
| AU641136B2 (en) | 1993-09-16 |
| ATE126052T1 (de) | 1995-08-15 |
| NO900428D0 (no) | 1990-01-30 |
| CA2009045A1 (en) | 1990-07-31 |
| HU205851B (en) | 1992-07-28 |
| JPH02282324A (ja) | 1990-11-19 |
| FI900470A0 (fi) | 1990-01-30 |
| DE69021405D1 (de) | 1995-09-14 |
| HUT53284A (en) | 1990-10-28 |
| EP0381181A3 (de) | 1991-09-18 |
| DE69021405T2 (de) | 1996-04-11 |
| JP2885858B2 (ja) | 1999-04-26 |
| EP0381181B1 (de) | 1995-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2085078B1 (de) | Osmotische osmosepumpe mit hochpermeablen arzneimitteln in tablettenform mit kontrollierter porosität und ihr herstellungsverfahren | |
| RU2073998C1 (ru) | Способ получения состава для регулированного выделения активных соединений | |
| US20040052844A1 (en) | Time-controlled, sustained release, pharmaceutical composition containing water-soluble resins | |
| IE61223B1 (en) | Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having improved core membrane adhesion properties | |
| NO20130984L (no) | Forlenget frigjøring - farmasøytisk tablett av metformin | |
| US20150246043A1 (en) | Oral dosage forms for modified release comprising ruxolitinib | |
| NO311403B1 (no) | Leveringsinnretning med innkapslede eksipienser og fremgangsmåte for avgivelse av et middel | |
| US10213389B2 (en) | Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride | |
| WO2021223480A1 (zh) | 一种替格瑞洛控释片及其制备方法 | |
| AU641136B2 (en) | A system for the controlled release of active agents and a process for its preparation | |
| EP1951210B1 (de) | Zusammensetzungen mit kontrollierter freisetzung aus einer kombination von isosorbiddinitrat und hydralazin-hydrochlorid | |
| US20220401446A1 (en) | Controlled release tofacitinib compositions | |
| CN112691086A (zh) | 微孔型琥珀酸美托洛尔缓释片及其制备方法 | |
| KR102589344B1 (ko) | 산 민감성 성분을 포함하는 삼투성 제제 조성물 | |
| JPH04360826A (ja) | 放出制御製剤 | |
| JP2567427B2 (ja) | 浸透分配経口投与製剤 | |
| US20090297602A1 (en) | Modified Release Loxoprofen Compositions | |
| US20070087056A1 (en) | Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility | |
| Kokane Prajakta et al. | INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES | |
| WO2014014427A1 (en) | Modified release pharmaceutical tablet formulations |